EcoDrugPlus

Toll Like Receptor 8

Ensembl ID : ENSEEUG00000006708
Gene Symbol: TLR8
3 External references
199 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSEEUG00000014479
Gene Symbol: TLR9
1 External references
82 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSEEUG00000013092
Gene Symbol: TGFBR1
1 External references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSEEUG00000013355
Gene Symbol: TRPV1
1 External references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSEEUG00000010707
Gene Symbol: TSPO
1 External references
122 Possible Orthologues:

Transthyretin

Ensembl ID : ENSEEUG00000004211
Gene Symbol: TTR
1 External references
166 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSEEUG00000009504
Gene Symbol: TPH1
1 External references
257 Possible Orthologues:

Tubulin Alpha 3c

Ensembl ID : ENSEEUG00000012442
Gene Symbol: TUBA3C
3 External references
153 Possible Orthologues:

Tubulin Alpha-1c Chain

Ensembl ID : ENSEEUG00000004068
Gene Symbol: LOC103109125
2 External references
178 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSEEUG00000003608
Gene Symbol: TUBB1
4 External references
186 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSEEUG00000014573
Gene Symbol: TP53
1 External references
254 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSEEUG00000004956
Gene Symbol: TYR
1 External references
266 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).